Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Slides:

Advertisements

Similar presentations

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Advertisements

Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Thomas J. Birdas, MD, Richard P. M

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small.

Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non–small cell lung cancer Kamran.

Local recurrence after surgery for non–small cell lung cancer: A recursive partitioning analysis of multi-institutional data Chris R. Kelsey, MD, Kristin.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Sai-Hong Ignatius Ou, MD, PhD, Jason.

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Arjun Pennathur, MD, Liqiang Xi, MD, Virginia R. Litle, MD, William E

Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non–small cell lung cancer

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Preliminary results of anatomic lung resection using energy-based tissue and vessel coagulative fusion technology Matthew J. Schuchert, MD, Ghulam Abbas,

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Stereotactic Radiosurgery/Stereotactic Body Radiotherapy for Recurrent Lung Neoplasm: An Analysis of Outcomes in 100 Patients Arjun Pennathur, MD, James.

John M. Varlotto, MD, Abram Recht, MD, John C. Flickinger, MD, Laura N

Benefits of resection for metachronous lung cancer

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial Stacey.

MicroRNA expression profiles of esophageal cancer

Lobar and sublobar resection with and without brachytherapy for small stage IA non– small cell lung cancer Hiran C. Fernando, FRCS, FRCSEd, Ricardo S.

Thomas J. Birdas, MD, Richard P. M

Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

The lord of the rings Antonio Miceli, MD, PhD

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Elizabeth A. David, MD, MAS, Stina W. Andersen, PhD, Laurel A

Segmentectomy for selected cT1N0M0 non–small cell lung cancer: A prospective study at a single institute Hiroaki Nomori, PhD, Takeshi Mori, PhD, Koei.

Yang Zhang, MD, Haiquan Chen, MD, PhD

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

A first start for lung transplantation?

Required area of lymph node sampling during segmentectomy for clinical stage IA non– small cell lung cancer Hiroaki Nomori, MD, PhD, Yasuomi Ohba, MD,

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Minimally invasive resection of benign esophageal tumors

Preoperative (3-dimensional) computed tomography lung reconstruction before anatomic segmentectomy or lobectomy for stage I non–small cell lung cancer

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Marginal pulmonary function should not preclude lobectomy in selected patients with non–small cell lung cancer Matthew D. Taylor, MD, Damien J. LaPar,

Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes Sitaram M. Emani, MD The Journal of Thoracic.

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

Sebastien Gilbert, MD, Andre B. Martel, BSc, Andrew J

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Matthew J. Schuchert, MD, André P

Matthew J. Schuchert, MD, Omar Awais, DO, Ghulam Abbas, MD, Zachary D

The future of cardiac surgery training: A survival guide

Linda W. Martin, MD, MPH, FCCP, FACS, Gail E

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Comparison of surgical techniques for early-stage thymoma: Feasibility of minimally invasive thymectomy and comparison with open resection Arjun Pennathur,

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

Aritoshi Hattori, MD, Kenji Suzuki, MD

Matthew J. Schuchert, MD, Brian L

Energized lung resections

Who should decide margin length in pulmonary excision of lung cancer?

Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer James B. Yu, MD, Roy H. Decker, MD, PhD,

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.

How do we follow up our patients

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Sebastien Gilbert, MD, David O. Wilson, MD, MPH, Neil A

Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W

Presentation transcript:

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R. Carr, MD, Matthew J. Schuchert, MD, Arjun Pennathur, MD, David O. Wilson, MD, Jill M. Siegfried, PhD, James D. Luketich, MD, Rodney J. Landreneau, MD The Journal of Thoracic and Cardiovascular Surgery Volume 143, Issue 2, Pages 390-397 (February 2012) DOI: 10.1016/j.jtcvs.2011.10.023 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Recurrence-free survival of all patients undergoing resection of pathologic stage 1A NSCLC (red). A significant difference in survival is noted when comparing T1a (blue) and T1b (green) tumors (P = .027). The Journal of Thoracic and Cardiovascular Surgery 2012 143, 390-397DOI: (10.1016/j.jtcvs.2011.10.023) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Recurrence-free survival for T1a and T1b tumors stratified by segmentectomy (A) and lobectomy (B). The Journal of Thoracic and Cardiovascular Surgery 2012 143, 390-397DOI: (10.1016/j.jtcvs.2011.10.023) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Recurrence-free survival curves comparing outcomes after segmentectomy or lobectomy for T1a (A) and T1b (B) tumors. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 390-397DOI: (10.1016/j.jtcvs.2011.10.023) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Cancer-specific survival curves comparing outcomes after segmentectomy or lobectomy for T1a (A) and T1b (B) tumors. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 390-397DOI: (10.1016/j.jtcvs.2011.10.023) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions